Search
for
Sort by
Research 91–120 of 702
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- JAK inhibitors in dermatology: The promise of a new drug class
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- Review of Promising Off-Label Use of Deucravacitinib
- Immune therapies for alopecia areata: evidence and new perspectives
- New and Emerging Therapies for Alopecia Areata
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Deucravacitinib in dermatology: current indication and existing off-label data
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- New Modalities in the Treatment of Refractory Alopecia Areata
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Targeting Cutaneous Cannabinoid Signaling in Inflammation - A “High”-way to Heal?
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Recent Advances in Drug Development for Hair Loss
- Treatment of pediatric alopecia areata: A systematic review
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- An Updated in the Management of Alopecia Areata
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib